Scanning Beam Proton Therapy (SPT) Versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and Outcomes.
05/03/2020
/
Publications
/
IMRT
This study reviewed dosimetric data and clinical outcomes of 64 stage III lung cancer patients treated with SPT (34) + IMRT (30). Mean dose to lung, heart, and...
Proton therapy for thoracic malignancies: a review of oncologic outcomes
01/01/2021
/
Publications
This review examined PBT physical properties, treatment techniques including the recent advances in planning and delivery, and clinical outcomes for each of the...
Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk.
10/10/2020
/
Publications
/
IMRT
Secondary cancer
This study estimated secondary cancer risks for 23 mediastinal lymphoma patients treated with PBT in comparison with helical photon IMRT re-plans. PBT was...
Proton pencil beam scanning reduces secondary cancer risk in breast cancer patients with internal mammary chain involvement compared to photon radiotherapy.
01/10/2020
/
Publications
/
Secondary cancer
This study compared tangential 3D-CRT and VMAT to PBS proton therapy in secondary cancer risk (SCR) for the lungs and for contralateral breast. PBS PT was...
Image-Guided Hypofractionated Proton Therapy in Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Study.
10/11/2020
/
Publications
/
Hypofractionation
Survival
22 patients with T1 to T2 N0M0 NSCLC received image-guided hypofractionated PBT to a total dose 48 GyRBE in 4 fractions for peripheral lesions and 60 GyRBE in...
Active-Scanned Protons and Carbon Ions in Cancer Treatment of Patients With Cardiac Implantable Electronic Devices: Experience of a Single Institution.
08/08/2019
/
Publications
A study by Heidelberg group looked into if ionizing radiation influenced the function of cardiac implantable electronic devices (CIED's) leading to malfunctions...
Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
07/10/2019
/
Publications
Six hundred sixty-nine patients with 682 tumors with histologically or clinically diagnosed Stage I NSCLC who received passive-scattering PBT in Japan were...
Proton therapy for locally advanced NSCLC
10/10/2019
/
Publications
A review article by MD Anderson group. Using particle-beam therapy rather than photons offers the potential for further advantages because of the unique depth...
Clinical Results of Proton Beam Therapy for Esophageal Cancer
07/07/2019
/
Publications
A large retrospective study of 202 patients (90 inoperable patients and 100 patients (49.5%) had stage III/IV cancer) who were treated with PBT in Japan. This...
Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced NSCLC patients treated with concurrent chemoradiotherapy
03/06/2019
/
Publications
This study evaluated pre-treatment and post-treatment F-FDG PET/CT of 18 locally advanced NSCLC patients treated with definitive photon or proton RT. In nine...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.